GVB Biopharma, a 22nd Century Group Company, is a large-scale Commercial manufacturer of Hemp-derived Pharmaceutical Cannabinoid grade Active Pharmaceutical Ingredients (APIs).

The 2022 submission of our US Cannabidiol (CBD) Drug Master File (DMF 37727) demonstrates GVB’s continuing commitment to supplying high quality pharmaceutical grade Cannabinoid APIs to the pharmaceutical industry and OTC markets.

Our ICH Q7 compliance quality infrastructure ensures that our customers consistently receive API that meets pharmaceutical API quality and regulatory standards.